Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q77667959)
Watch
English
Systemic adjuvant treatment of high-risk melanoma: the role of interferon alfa-2b and other immunotherapies
scientific article published on 01 July 1998
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
9849403
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849403%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Systemic adjuvant treatment of high-risk melanoma: the role of interferon alfa-2b and other immunotherapies
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
9849403
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849403%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
main subject
immunotherapy
1 reference
based on heuristic
inferred from title
immunologic adjuvant
1 reference
based on heuristic
inferred from title
author name string
J M Kirkwood
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
9849403
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849403%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
publication date
1 July 1998
1 reference
stated in
Europe PubMed Central
PubMed ID
9849403
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849403%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
published in
European Journal of Cancer
1 reference
stated in
Europe PubMed Central
PubMed ID
9849403
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849403%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
volume
34 Suppl 3
1 reference
stated in
Europe PubMed Central
PubMed ID
9849403
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849403%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
page(s)
S12-7
1 reference
stated in
Europe PubMed Central
PubMed ID
9849403
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849403%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
cites work
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910159-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910159-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910159-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Model predicting survival in stage I melanoma based on tumor progression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910159-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910159-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910159-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910159-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferons in the treatment of human cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910159-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferons in the treatment of malignant melanoma. A review of recent trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910159-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910159-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910159-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The prognostic significance of immune changes in patients with renal cancer, melanoma and colorectal cancer, treated with interferon alpha 2b
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910159-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Future perspectives in specific immunotherapy of melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910159-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0959-8049(97)10159-9
1 reference
stated in
Europe PubMed Central
PubMed ID
9849403
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849403%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
PubMed ID
9849403
1 reference
stated in
Europe PubMed Central
PubMed ID
9849403
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849403%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
